Episode 15 – Christopher Micetich

On this 15th episode of the AMR Action Podcast, Christopher Micetich, President and CEO of both Brass Dome Ventures Ltd. and Fedora Pharmaceuticals Inc., joins Dani Peters, CAIC Senior Advisor, to discuss the current state of antimicrobial innovation within the biotech industry and the challenges faced in developing new solutions. He shares some of the history of antimicrobial innovation in Alberta, including the discovery of Tazobactam by his late father and team of researchers, and suggests how Alberta can position itself as a leader in antimicrobial innovation on a global scale, leveraging the upcoming G7 summit hosted in the region.